Header cover image

Japanese (NIKKEI) Clinical Research and Equipment Industry Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies15
  • 7D-4.6%
  • 3M-10.4%
  • 1Y-34.8%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 4.9%, driven by Shin Nippon Biomedical Laboratories declining 6.5%. The industry has fallen 35% in the last year. As for the next few years, earnings are expected to grow by 11% per annum.

Industry Valuation and Performance

Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jul 2024JP¥162.0bJP¥61.8bJP¥3.2b25.1x50.1x2.6x
Sun, 23 Jun 2024JP¥162.9bJP¥61.8bJP¥3.2b26x50.3x2.6x
Tue, 21 May 2024JP¥168.0bJP¥62.1bJP¥3.2b17.3x51.8x2.7x
Thu, 18 Apr 2024JP¥180.6bJP¥62.3bJP¥3.3b14.2x54.9x2.9x
Sat, 16 Mar 2024JP¥227.6bJP¥155.4bJP¥8.6b13.8x26.4x1.5x
Mon, 12 Feb 2024JP¥232.8bJP¥156.2bJP¥9.0b14.6x25.8x1.5x
Wed, 10 Jan 2024JP¥232.6bJP¥167.1bJP¥8.5b15.6x27.4x1.4x
Fri, 08 Dec 2023JP¥231.5bJP¥167.4bJP¥8.7b15x26.7x1.4x
Sun, 05 Nov 2023JP¥225.7bJP¥179.4bJP¥12.9b14.3x17.5x1.3x
Tue, 03 Oct 2023JP¥248.2bJP¥179.3bJP¥12.8b15.5x19.4x1.4x
Thu, 31 Aug 2023JP¥267.8bJP¥179.3bJP¥12.8b16.8x20.9x1.5x
Sat, 29 Jul 2023JP¥268.7bJP¥178.7bJP¥15.7b16.1x17.2x1.5x
Mon, 26 Jun 2023JP¥285.8bJP¥178.5bJP¥16.2b17.1x17.6x1.6x
Wed, 24 May 2023JP¥279.8bJP¥178.1bJP¥15.9b15.8x17.6x1.6x
Fri, 21 Apr 2023JP¥286.0bJP¥171.9bJP¥13.3b16.5x21.5x1.7x
Sun, 19 Mar 2023JP¥318.6bJP¥171.9bJP¥13.3b16.6x24x1.9x
Tue, 14 Feb 2023JP¥303.4bJP¥171.3bJP¥13.1b16.8x23.2x1.8x
Thu, 12 Jan 2023JP¥297.5bJP¥166.1bJP¥16.2b14.8x18.4x1.8x
Sat, 10 Dec 2022JP¥318.1bJP¥165.5bJP¥16.0b14.7x19.9x1.9x
Mon, 07 Nov 2022JP¥308.6bJP¥161.3bJP¥13.2b16.4x23.5x1.9x
Wed, 05 Oct 2022JP¥322.9bJP¥160.1bJP¥12.4b17.3x26.1x2x
Fri, 02 Sep 2022JP¥319.8bJP¥159.7bJP¥12.3b18.1x26.1x2x
Sun, 31 Jul 2022JP¥304.7bJP¥152.8bJP¥10.9b18.6x28.1x2x
Tue, 28 Jun 2022JP¥280.2bJP¥152.8bJP¥10.9b17.1x25.7x1.8x
Thu, 26 May 2022JP¥241.9bJP¥152.7bJP¥10.9b17.8x22.2x1.6x
Sat, 23 Apr 2022JP¥247.7bJP¥144.9bJP¥10.6b20.2x23.3x1.7x
Mon, 21 Mar 2022JP¥227.8bJP¥144.9bJP¥10.6b20.1x21.5x1.6x
Wed, 16 Feb 2022JP¥243.1bJP¥144.7bJP¥10.9b18.9x22.2x1.7x
Fri, 14 Jan 2022JP¥266.0bJP¥136.0bJP¥6.8b21.4x39.4x2x
Sun, 12 Dec 2021JP¥330.1bJP¥135.7bJP¥6.9b25x47.9x2.4x
Tue, 09 Nov 2021JP¥417.8bJP¥207.6bJP¥10.3b25.9x40.4x2x
Thu, 07 Oct 2021JP¥352.5bJP¥198.7bJP¥8.1b25.9x43.7x1.8x
Sat, 04 Sep 2021JP¥365.8bJP¥201.8bJP¥5.0b25.4x72.5x1.8x
Mon, 02 Aug 2021JP¥355.0bJP¥201.8bJP¥5.0b25.5x70.4x1.8x
Price to Earnings Ratio

70.4x


Total Market Cap: JP¥355.0bTotal Earnings: JP¥5.0bTotal Revenue: JP¥201.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Clinical Research and Equipment Industry Price to Earnings3Y Average 30.6x202220232024
Current Industry PE
  • Investors are optimistic on the Japanese Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 50.2x which is higher than its 3-year average PE of 30.6x.
  • The 3-year average PS ratio of 1.8x is lower than the industry's current PS ratio of 2.6x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have declined 14% per year over the last three years,
  • Revenues have also declined 33% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Comparison

How does Japanese Clinical Research and Equipment compare with similar industries?

JP Market-5.18%
Healthcare-2.00%
Life Sciences-4.60%
Clinical Research and Equipment-4.60%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4880 CellSourceJP¥1.52k1.9%
+JP¥574.4m
-30.2%PE37x
2309 CMIC HOLDINGSJP¥2.64k0.2%
+JP¥84.5m
26.6%PE8.4x
6190 PhoenixBioJP¥531.002.1%
+JP¥44.6m
-6.3%PE82.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.